Navigation Links
Eric Tornoe Joins Exagen Diagnostics as President and COO
Date:8/10/2011

ALBUQUERQUE, N.M., Aug. 10, 2011 /PRNewswire/ -- Exagen Diagnostics, Inc., a specialty focused molecular diagnostics laboratory that discovers, develops and markets proprietary tests for rheumatologists and gastroenterologists, announced today the appointment of Eric Tornoe as President and Chief Operating Officer.

Tornoe has more than 20 years of healthcare industry experience in sales, sales management and marketing, making him a key hire as Exagen broadens its test menu and moves to the next level of growth.  Prior to Exagen, he worked for Pfizer Inc., Wyeth and Bristol-Myers Squibb Co., quickly advancing his career in a number of senior management positions that dramatically expanded revenues.  He has a reputation for building effective business units, creating partnerships and developing collaborative relationships.  Tornoe has a depth of operational expertise in the rheumatology market and a track record of successfully developing and implementing strategic plans.

"This is an exciting time at Exagen as our product line expands and sales grow," said Scott Glenn, board chairman and CEO.  "Eric has a great track record in leading and directing teams to exceed corporate business and revenue objectives.   He will play an instrumental role in the ongoing success of the company and its continued focus on personalized medicine."

About Exagen

Exagen is the emerging leader in laboratory-discovered and developed genomic tests specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. Using Coperna, the company's proprietary, algorithm-driven computational tool and search engine that runs on high-performance computational clusters, it combines the ability to process massive amounts of data contained in genomic datasets with intelligent, rapid search methods. Coperna's targeted and precise discovery model has no conventional equivalent in the molecular diagnostics industry as it can identify relevant marker sets with superior sensitivity and specificity relative to markers identified via traditional analytical methods. For more information, please visit www.exagen.com.


'/>"/>
SOURCE Exagen Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Kelly Price Joins Los Angeles County Affiliate of Susan G. Komen for the Cure in the Fight Against Breast Cancer
2. Andrea Drucker Joins Insmed as General Counsel
3. Coloredge New York - Los Angeles Joins DuPont™ Tyvek® Graphics Authorized Printer Network
4. Jeff Sherman Joins Block Engineering as Vice President of Worldwide Sales
5. Laszlo Radvanyi, Ph.D. Joins Genesis Biopharma Scientific and Medical Advisory Board
6. Dr. Joel Posener Joins PharmaNet as Executive Medical Director, Neuroscience
7. Eduard Alberts, Ph.D. Joins Sanford Rose Associates - San Francisco
8. Amicus Therapeutics Joins Russell 3000® Index
9. Dr. H. Daniel Perez Joins Celtaxsys Board of Directors
10. Governor Gray Davis Joins Genesis Biopharma as Chairman of Corporate Advisory Board
11. Matthias Spaenle, MD, Joins Oppenheimers Investment Banking Group as Managing Director - Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ... for North American hospitals, will present its chain-of-custody solution for tracking and securing ... Las Vegas, Nev., Dec. 4-8, 2016. , Aerocom has a proven solution for ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... ALBANY, New York , November 30, 2016 /PRNewswire/ ... exceptionally consolidated as a few players hold a dominant ... Lonza Group, Charles River Laboratories International, Inc., and Merck ... global market in 2015. Transparency Market Research observes that ... they are focused on development products that are do ...
Breaking Biology Technology:
(Date:6/21/2016)... 2016 NuData Security announced today that Randy ... principal product architect and that Jon Cunningham ... development. Both will report directly to Christopher ... reflect NuData,s strategic growth in its product and ... demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... innovation leader in attendance control systems is proud to announce the introduction of fingerprint ... sure the right employees are actually signing in, and to even control the opening ... ... ... Photo ...
Breaking Biology News(10 mins):